As of 2025-09-15, the Relative Valuation of Rhythm Pharmaceuticals Inc (RYTM) is (64.36) USD. This relative valuation is based on P/E multiples. With the latest stock price at 96.03 USD, the upside of Rhythm Pharmaceuticals Inc based on Relative Valuation is -167.0%.
The range of the Relative Valuation is (50.88) - (64.93) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.6x - 23.6x | 22.3x |
| Forward P/E multiples | 18.5x - 27.6x | 24.4x |
| Fair Price | (50.88) - (64.93) | (64.36) |
| Upside | -153.0% - -167.6% | -167.0% |
| Date | P/E |
| 2025-09-10 | -36.38 |
| 2025-09-09 | -36.81 |
| 2025-09-08 | -36.20 |
| 2025-09-05 | -37.05 |
| 2025-09-04 | -37.94 |
| 2025-09-03 | -36.90 |
| 2025-09-02 | -37.81 |
| 2025-08-29 | -37.43 |
| 2025-08-28 | -37.82 |
| 2025-08-27 | -37.12 |
| 2025-08-26 | -36.72 |
| 2025-08-25 | -35.99 |
| 2025-08-22 | -37.47 |
| 2025-08-21 | -36.89 |
| 2025-08-20 | -35.81 |
| 2025-08-19 | -35.26 |
| 2025-08-18 | -35.59 |
| 2025-08-15 | -35.42 |
| 2025-08-14 | -35.01 |
| 2025-08-13 | -35.51 |
| 2025-08-12 | -35.00 |
| 2025-08-11 | -34.22 |
| 2025-08-08 | -33.37 |
| 2025-08-07 | -33.55 |
| 2025-08-06 | -32.66 |
| 2025-08-05 | -32.14 |
| 2025-08-04 | -32.74 |
| 2025-08-01 | -32.04 |
| 2025-07-31 | -30.92 |
| 2025-07-30 | -30.72 |
| 2025-07-29 | -31.07 |
| 2025-07-28 | -31.09 |
| 2025-07-25 | -31.37 |
| 2025-07-24 | -31.66 |
| 2025-07-23 | -31.86 |
| 2025-07-22 | -31.86 |
| 2025-07-21 | -32.16 |
| 2025-07-18 | -32.36 |
| 2025-07-17 | -32.90 |
| 2025-07-16 | -33.18 |
| 2025-07-15 | -32.42 |
| 2025-07-14 | -32.35 |
| 2025-07-11 | -31.46 |
| 2025-07-10 | -32.31 |
| 2025-07-09 | -32.29 |
| 2025-07-08 | -23.63 |
| 2025-07-07 | -24.09 |
| 2025-07-03 | -23.86 |
| 2025-07-02 | -24.28 |
| 2025-07-01 | -23.74 |